Phase 1 (Weeks 1 to 2): 0.25 mg subcutaneous injection once daily, morning on empty stomach Phase 2 (Weeks 3 to 6): Maintain 0.25 mg or increase to 0.5 mg based on response and tolerance Phase 3 (Weeks 7 to 8): Continue or begin taper depending on symptom improvement Maintenance: Consider cycling 4 weeks on, 2 weeks off for long-term management Oral dosing requires higher amounts to compensate for bioavailability differences
Proteins with a fold change (FC) 1.5 or FC 0.6667, coupled with a P -value 0.05, were defined as significantly differential proteins (DEPs)
S.GuoA.OlerE.WangF.AnjumA.PetersH.et al
Amphibians and Reptiles of Pennsylvania and the Northeast (Cornell University Press, 2001), pp
10.1074/jbc.m310329200 9 BattagliaA.PakK.BrorsD.BodmerD.FrangosJ
Low-Dose Tricyclic Antidepressants Tricyclic antidepressants (TCAs) impair gastrointestinal motility through their anticholinergic activity but they have also been shown to relieve nausea, vomiting and pain in functional dyspepsia